JPH10305088A - Antimicrobial agent to which deodorizability is imparted - Google Patents

Antimicrobial agent to which deodorizability is imparted

Info

Publication number
JPH10305088A
JPH10305088A JP9135928A JP13592897A JPH10305088A JP H10305088 A JPH10305088 A JP H10305088A JP 9135928 A JP9135928 A JP 9135928A JP 13592897 A JP13592897 A JP 13592897A JP H10305088 A JPH10305088 A JP H10305088A
Authority
JP
Japan
Prior art keywords
test
gel
hinokitiol
sample
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9135928A
Other languages
Japanese (ja)
Inventor
Nobuhiro Suzuki
信弘 鈴木
Akira Miyaki
昭 宮木
Hatsuo Toyama
初夫 遠山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOSOKUBO KAZUHIRO
Original Assignee
HOSOKUBO KAZUHIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HOSOKUBO KAZUHIRO filed Critical HOSOKUBO KAZUHIRO
Priority to JP9135928A priority Critical patent/JPH10305088A/en
Publication of JPH10305088A publication Critical patent/JPH10305088A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To provide an antimicrobial agent which consists of the components derived from plants as its effective component and to which deodorizability is imparted and an antimicrobial agent which is effective for food poisoning bacteria including enterophanogenic E. coli O-157. SOLUTION: This antimicrobial agent contains 'Smellnark (R)' and org. matter having a tropolone skeleton. An emulsifier is preferably incorporated further therein in addition to the 'Smellnark (R)' and the org. matter having the tropolone skeleton. The org. matter having the tropolone skeleton is preferably hinokitiol. Further, the antimicrobial agent is recommended to be made into gelatinous matter by adding a gelatinizing agent thereto.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、植物由来の成分を
その有効成分とする消臭性を付与した抗菌剤に関するも
のである。
TECHNICAL FIELD The present invention relates to an antibacterial agent having a deodorant property, comprising a plant-derived component as its active ingredient.

【0002】[0002]

【従来の技術】一般に植物性の消臭剤は、植物の葉、茎
などから圧搾法、真空乾留法などにより有機化合物を抽
出し、何種類かの植物から抽出した有機化合物を混合し
たもので、植物由来の成分を有効成分としており安全性
が高く望ましい。しかし、このような消臭剤には一般的
に抗菌性は付与されておらず、抗菌性と消臭性とを併せ
もつ消臭性抗菌剤が望まれている。ところで、近年は、
調理施設等での暖房設備の普及等により食中毒菌による
食中毒が時期を問わず、各所で発生しているのが現状で
あり、特に病原性大腸菌O157は感染源の特定も困難
で大きな社会問題となっている。
2. Description of the Related Art Generally, a plant deodorant is obtained by extracting organic compounds from leaves, stems, etc. of a plant by a squeezing method, vacuum distillation, or the like, and mixing the organic compounds extracted from several types of plants. It has high safety because it contains plant-derived components as active ingredients. However, antibacterial properties are not generally imparted to such deodorants, and deodorant antibacterial agents having both antibacterial properties and deodorant properties are desired. By the way, in recent years,
At present, food poisoning due to food poisoning bacteria is occurring everywhere due to the spread of heating facilities in cooking facilities, etc. Especially, pathogenic Escherichia coli O157 is difficult to identify the source of infection. Has become.

【0003】[0003]

【発明が解決しようとする課題】そこで、本発明の目的
は、植物由来の成分をその有効成分とする、消臭性を付
与した抗菌剤を提供することにある。特に、病原性大腸
菌O157をはじめとする食中毒菌に対しても有効な抗
菌剤を提供することにある。
SUMMARY OF THE INVENTION Accordingly, an object of the present invention is to provide an antibacterial agent having a deodorant property, comprising a plant-derived component as its active ingredient. In particular, it is to provide an effective antibacterial agent against food poisoning bacteria such as pathogenic Escherichia coli O157.

【0004】[0004]

【課題を解決するための手段】上記課題を解決するため
に、本発明者は鋭意研究の結果、多数の植物から抽出し
た植物エキスを有効成分とするある特定の消臭剤に、抗
菌効果のあるとされるヒノキチオールなどのトロポトン
骨格を有する有機物を配合することにより、高い消臭効
果と高い抗菌効果とを併せもたせることができることを
見出し、本発明を完成した。即ち、本発明の消臭性を付
与した抗菌剤は、商品名スメルナークとトロポロン骨格
をもつ有機物とを含んでなること、を特徴としている。
また、前記商品名スメルナークとトロポロン骨格をもつ
有機物に加えて、さらに乳化剤を含有させることが好ま
しい。また、前記トロポロン骨格をもつ有機物としては
ヒノキチオールが好ましい。さらにゲル化剤を添加して
ゲル状物とするとよい。
Means for Solving the Problems In order to solve the above problems, the present inventors have conducted intensive studies and found that a specific deodorant containing a plant extract extracted from many plants as an active ingredient has an antibacterial effect. By finding that an organic substance having a tropoton skeleton such as hinokitiol is blended, it has been found that both a high deodorizing effect and a high antibacterial effect can be obtained, and the present invention has been completed. That is, the antibacterial agent imparted with deodorant properties of the present invention is characterized by comprising Smernak (trade name) and an organic substance having a tropolone skeleton.
In addition, it is preferable that an emulsifier is further contained in addition to the organic substance having a trade name of Smernak and a tropolone skeleton. Further, as the organic substance having the tropolone skeleton, hinokitiol is preferable. It is preferable to add a gelling agent to form a gel.

【0005】[0005]

【発明の実施の形態】以下、本発明の実施の形態を具体
的に説明する。本発明における、商品名スメルナーク
は、株式会社東海興産製の消臭剤で、杉、桧、樅、イラ
クサ、楠、黒松、赤松、エゾマツ、柿、熊笹、ヨモギ、
茶、白樺、シソアロエ、サンショウ、アマ茶ズル等を主
原料とした35種類の植物から独特な圧搾装置と真空乾
留装置により約180種類の有機化合物を抽出し、これ
らをブレンドした抽出エキスである。かかる抽出エキス
は水溶性で、高い消臭効果を有している。
DESCRIPTION OF THE PREFERRED EMBODIMENTS Embodiments of the present invention will be specifically described below. In the present invention, trade name Smernak is a deodorant manufactured by Tokai Kosan Co., Ltd., cedar, cypress, fir, nettle, camphor, black pine, red pine, spruce, persimmon, kumasasa, mugwort,
It is an extract that extracts about 180 kinds of organic compounds from 35 kinds of plants mainly composed of tea, birch, perilla aloe, sunshaw, ama tea slurries, etc. by using a unique squeezing device and vacuum distillation device, and blends them. . Such an extract is water-soluble and has a high deodorizing effect.

【0006】トロポロン骨格をもつ有機物としては、例
えば、ヒノキチオール(β−ツヤプリシン)、β−ドラ
ブリン、これらの誘導体などが挙げられる。ここで、ヒ
ノキチオールは、青森産ヒバ油、台湾ヒノキ油、ウェス
タン・レッド・シーダー油などの中に存在する油溶性の
結晶性物質で、強い抗菌性を有している。また、β−ド
ラブリンは、青森産ヒバ油中に含まれ、ヒノキチオール
と同等の抗菌性をもつ。
Examples of the organic substance having a tropolone skeleton include hinokitiol (β-thyaprisin), β-drabulin, and derivatives thereof. Here, hinokitiol is an oil-soluble crystalline substance present in Aomori-grown hiba oil, Taiwan hinoki oil, Western Red Cedar oil and the like, and has strong antibacterial properties. Β-Drabulin is contained in Aomori Hiba oil and has an antibacterial property equivalent to that of Hinokitiol.

【0007】上記商品名スメルナークは水溶性であり、
トロポロン骨格をもつ有機物としてのヒノキチオールは
油溶性であるので、これらを均一に混合するには、乳化
剤(界面活性剤)を添加する。このような乳化剤として
は、ヒマシ油など両者を均一に混合させてエマルジョン
化できるものであれば特に制限はない。さらに、有機
酸、有機酸塩ないし有機酸エステルを添加すると、乳化
性が増す。このような有機酸類としては、例えばクエン
酸、クエン酸ナトリウム、クエン酸トリエチルなどが挙
げられる。また、溶媒としては、水を用いるが、ヒノキ
チオールがアルコール溶解性をもつので、アルコールを
添加することもできる。ここで用いる水は、塩素やミネ
ラル分などの不純物を含まないイオン交換水が好まし
い。
[0007] The above-mentioned trade name Smernak is water-soluble,
Since hinokitiol as an organic substance having a tropolone skeleton is oil-soluble, an emulsifier (surfactant) is added to uniformly mix them. Such an emulsifier is not particularly limited as long as both can be uniformly mixed and emulsified, such as castor oil. Further, when an organic acid, an organic acid salt or an organic acid ester is added, the emulsifiability is increased. Examples of such organic acids include citric acid, sodium citrate, triethyl citrate and the like. Water is used as the solvent, but alcohol can also be added because hinokitiol has alcohol solubility. The water used here is preferably ion-exchanged water that does not contain impurities such as chlorine and minerals.

【0008】上記各成分の配合割合は用いる成分の種類
により変動はあるが、トロポロン骨格をもつ有機物とし
てヒノキチオールを用いた場合、スメルナーク0.3〜
30重量%、ヒノキチオール0.1〜2重量%、乳化剤
0.5〜10重量%、有機酸類0.5〜5重量%程度
で、残部溶媒とする。スメルナークの添加量が少なすぎ
ると消臭効果が不十分となり、多すぎるとコスト高とな
る。ヒノキチオールの添加量が少なすぎると十分な抗菌
効果が得られず、多すぎるとコスト高となる。乳化剤や
有機酸類の添加量が少なすぎるとエマルジョン化が不十
分となりヒノキチオールが結晶化して析出してしまい、
一方多すぎると乳化剤等が白濁化し沈殿物が多くなる。
Although the mixing ratio of the above components varies depending on the type of components used, when hinokitiol is used as an organic substance having a tropolone skeleton, Smernak 0.3 to
About 30% by weight, about 0.1 to 2% by weight of hinokitiol, about 0.5 to 10% by weight of an emulsifier, and about 0.5 to 5% by weight of organic acids. If the amount of Smelnark is too small, the deodorizing effect becomes insufficient, and if it is too large, the cost increases. If the amount of hinokitiol is too small, a sufficient antibacterial effect cannot be obtained, and if it is too large, the cost increases. If the addition amount of the emulsifier and the organic acids is too small, the emulsification becomes insufficient and the hinokitiol crystallizes and precipitates,
On the other hand, if it is too large, the emulsifier and the like become cloudy and the amount of precipitate increases.

【0009】使用形態としては、水溶液(液状物)とし
て用いることもできるが、冷蔵庫、車中、室内などで用
いるには、ゲル状物として容器に入れ有効成分を揮発さ
せるようにして用いるのが便利である。ゲル状物とする
には吸水性樹脂を添加すればよい。スメルナークやヒノ
キチオールなどの有効成分は揮発性をもち、ゲル状物と
することにより表面積を大きくして有効成分の揮発を促
し、消臭効果及び抗菌効果を高めることができる。ゲル
状物として空気中に放置すると、吸水性樹脂中の水が蒸
発するが、このとき、樹脂の表面に吸着している有効成
分を伴いながら蒸発する。
As a form of use, it can be used as an aqueous solution (liquid substance). However, for use in refrigerators, cars, indoors, etc., it is preferable to put it in a container as a gel to volatilize the active ingredient. It is convenient. In order to obtain a gel, a water-absorbing resin may be added. Active ingredients such as smernak and hinokitiol have volatility, and by making them into a gel, the surface area is increased to promote the volatilization of the active ingredients, thereby improving the deodorizing effect and the antibacterial effect. When left in the air as a gel, the water in the water-absorbent resin evaporates. At this time, the water evaporates with the active ingredient adsorbed on the surface of the resin.

【0010】ゲル状物として用いる場合、ゲル状物全体
に対して吸水性樹脂4〜10重量%程度配合する。配合
割合が少なすぎると表面積が不足し有効成分の揮発性が
悪くなり、多すぎると揮発性は良くなるが、かさ比重が
小さくなり、同量の有効性分を含ませるのに大きな容器
を用いなければならなくなる。
When used as a gel, the water-absorbing resin is blended in an amount of about 4 to 10% by weight based on the whole gel. If the compounding ratio is too small, the surface area becomes insufficient and the volatility of the active ingredient deteriorates, and if it is too large, the volatility improves, but the bulk specific gravity becomes small, and a large container is used to contain the same amount of the effective component. I have to.

【0011】[0011]

【実施例】以下に本発明の実施例を挙げてさらに具体的
に説明する。これらの実施例は特許請求の範囲を限定す
るものではない。〔抗菌効果試験〕商品名「スメルナー
ク」単独、カテキン単独、ヒノキチオール単独、「スメ
ルナーク」とヒノキチオールとの混合物、のそれぞれに
ついて抗菌効果を試験した。
The present invention will be described more specifically with reference to the following examples. These examples do not limit the scope of the claims. [Antibacterial effect test] The antibacterial effect was tested for each of the brand name "Smernark" alone, catechin alone, hinokitiol alone, and a mixture of "Smernark" and hinokitiol.

【0012】実験例1 商品名「スメルナーク」の所定濃度の溶液を試験液と
し、この試験液に大腸菌(血清型O157:H7)の菌
液を接種した後、室温で作用させ、経時的に試験液中の
生残菌の有無を調べた。
EXPERIMENTAL EXAMPLE 1 A solution having a predetermined concentration of "Smernark" (trade name) was used as a test solution, and the test solution was inoculated with a bacterial solution of Escherichia coli (serotype O157: H7), allowed to act at room temperature, and tested with time. The presence or absence of surviving bacteria in the liquid was examined.

【0013】試験菌株として大腸菌,血清型O157:
H7,ベロ毒素非産生株(Escherichia coli ATCC 4388
8 )を用い、NA培地(普通寒天培地(栄研化学株式会社
製))で37±1℃、16〜24時間前培養した試験菌
株をNA培地に再度接種して37±1℃、16〜20時間
培養した菌体を生理食塩水に均一に分散させ、1ml当
たりの菌数が約108 となるように菌液を調製した。試
験液としては、検体(商品名「スメルナーク」)原液そ
のまま、検体の10、5、2.5%(V/V)溶液を調
製し試験液とした。そして、試験液10mlに菌液1m
lを接種し、室温で作用させ、0.5、1、3、6時間
後に、一白金耳量をNB培地(肉エキス0.2%を添加し
た普通ブイヨン(栄研化学株式会社製))に接種・培養
(37℃2日間培養)し、生育の有無を確認した。その
結果を表1に示す。表中の符号+は生育有り、符号−は
生育無しをそれぞれ示す。
Escherichia coli, serotype O157 as a test strain:
H7, non-verotoxin-producing strain (Escherichia coli ATCC 4388
8), a test strain pre-cultured at 37 ± 1 ° C. for 16 to 24 hours in an NA medium (ordinary agar medium (manufactured by Eiken Chemical Co., Ltd.)) was again inoculated into the NA medium, and then inoculated at 37 ± 1 ° C., 16 to The cells cultured for 20 hours were uniformly dispersed in physiological saline, and a bacterial solution was prepared so that the number of cells per ml was about 10 8 . As a test solution, a 10, 5, 2.5% (V / V) solution of the sample was prepared as a sample (trade name “Smernark”) undiluted solution and used as a test solution. Then, 1m of bacterial solution is added to 10ml of test solution.
1 and inoculated at room temperature, and after 0.5, 1, 3 and 6 hours, one loopful of NB medium (Normal broth with 0.2% meat extract (manufactured by Eiken Chemical Co., Ltd.)) Was inoculated and cultured (cultured at 37 ° C. for 2 days) to check for growth. Table 1 shows the results. The sign + in the table indicates that there is growth, and the sign-indicates that there is no growth.

【0014】[0014]

【表1】 表1 殺菌効果試験結果((財)日本食品分析センター調べ) 試 験 菌 検体濃度 生 育 の 有 無 %(V/V) 30分後 1時間後 3時間後 6時間後 大腸菌 100(原液) + − − − (血清型 10 + + + + O157:H7) 5 + + + + 2.5 + + + + [Table 1] Table 1 Bactericidal effect test results (according to Japan Food Research Laboratories) Test bacteria Sample concentration Growth % (V / V) 30 minutes 1 hour 3 hours 6 hours later Escherichia coli 100 (stock solution) +---(serotype 10 + + + + O157: H7) 5 + + + + + + + + + +

【0015】実験例2 検体としてカテキンを用い、カテキンを精製水で1.
0、0.5、0.1%(W/V)溶液を調製して試験液
とした他は実験例1と同様に試験した。その結果を表2
に示す。
Experimental Example 2 Catechin was used as a sample, and catechin was purified with purified water.
The test was conducted in the same manner as in Experimental Example 1 except that 0, 0.5, and 0.1% (W / V) solutions were prepared and used as test solutions. Table 2 shows the results.
Shown in

【0016】[0016]

【表2】 表2 殺菌効果試験結果((財)日本食品分析センター調べ) 試 験 菌 検体濃度 生 育 の 有 無 %(V/V) 30分後 1時間後 3時間後 6時間後 大腸菌 1.0 + + + + (血清型 0.5 + + + + O157:H7) 0.1 + + + + [Table 2] Table 2 Bactericidal effect test results (according to Japan Food Research Laboratories) Test bacteria Sample concentration Growth % (V / V) 30 minutes 1 hour 3 hours 6 hours later E. coli 1.0 ++++++ (serotype 0.5 ++++ O157: H7) 0.1 ++++

【0017】実験例3 検体としてヒノキチオールを用い、ヒノキチオールを5
%(V/V)エタノール溶液で1.0、0.1、0.0
1及び0%(W/V)溶液を調製して試験液とした他は
実験例1と同様に試験した。その結果を表3に示す。
EXPERIMENTAL EXAMPLE 3 Hinokitiol was used as a sample, and 5
% (V / V) 1.0, 0.1, 0.0 with ethanol solution
A test was conducted in the same manner as in Experimental Example 1 except that 1 and 0% (W / V) solutions were prepared and used as test solutions. Table 3 shows the results.

【0018】[0018]

【表3】 表3 殺菌効果試験結果((財)日本食品分析センター調べ) 試 験 菌 検体濃度 生 育 の 有 無 %(V/V) 15分後 30分後 1時間後 3時間後 6時間後 大腸菌 1.0 + + − − − (血清型 0.1 + + + + + O157:H7) 0.01 + + + + + 0 + + + + + [Table 3] Table 3 Bactericidal effect test results (according to Japan Food Research Laboratories) Test bacteria Sample concentration % (V / V) 15 minutes 30 minutes 1 hour 3 hours 6 hours later Escherichia coli 1.0 + +---(serotype 0.1 + + + + + O157: H7) 0.01 + + + + + 0 + + ++++

【0019】実験例4 検体1)として商品名「スメクナール」を、検体2)と
してヒノキチオールを用い、検体1)の2.5%(V/
V)溶液に検体2)を約1%添加したものを試験液と
し、この試験液に各種細菌の菌液を接種し、室温で作用
させ、経時的に試験液中の生残菌の有無を調べた。
Experimental Example 4 Sample 1) was trade name "Smecnal" and sample 2) was hinokitiol, and 2.5% (V / V) of sample 1).
V) A solution obtained by adding about 1% of the sample 2) to the solution is used as a test solution, and bacterial solutions of various bacteria are inoculated into the test solution and allowed to act at room temperature, and the presence or absence of surviving bacteria in the test solution is determined over time. Examined.

【0020】試験菌株として(1)大腸菌,血清型O1
57:H7,ベロ毒素非産生株(Escherichia coli ATC
C 43888 )、(2)大腸菌(Escherichia coli IFO 397
2 )、(3)黄色ブドウ球菌(Staphylococcus aureus
IFO 12732 )、(4)サルモネラ(Salmonella enterit
idis IFO 3313 )、(5)腸炎ビブリオ(Vibrio parah
aemolyticus IFO 12711 )を用い、大腸菌(O157 : H
7 )、大腸菌、黄色ブドウ球菌及びサルモネラについて
は、NA培地(普通寒天培地(栄研化学株式会社製))で
37±1℃、16〜24時間前培養した試験菌株をNA培
地に再度接種して37±1℃、16〜20時間培養した
菌体を生理食塩水に均一に分散させ、1ml当たりの菌
数が約108となるように菌液を調製した。また、腸炎
ビブリオについては、3%NaCl添加NA培地(塩化ナ
トリウム3%を添加したNA培地)で37±1℃、16〜
24時間前培養した試験菌株を3%NaCl添加NA培地
に再度接種して37±1℃、16〜20時間培養した菌
体を3%塩化ナトリウム溶液に均一に分散させ、1ml
当たりの菌数が約108 となるように菌液を調製した。
検体1)の2.5%(V/V)溶液80mlに、検体
2)の20%(W/V)エタノール溶液4mlを添加し
たものを試験液とした。
As test strains (1) Escherichia coli, serotype O1
57: H7, non-verotoxin-producing strain (Escherichia coli ATC
C 43888), (2) Escherichia coli IFO 397
2), (3) Staphylococcus aureus
IFO 12732), (4) Salmonella enterit
idis IFO 3313), (5) Vibrio parahaemolyticus (Vibrio parah)
aemolyticus IFO 12711) and E. coli (O157: H
7) For Escherichia coli, Staphylococcus aureus and Salmonella, a test strain pre-cultured at 37 ± 1 ° C. for 16 to 24 hours in NA medium (normal agar medium (manufactured by Eiken Chemical Co., Ltd.)) was inoculated again into NA medium. The cells cultured at 37 ± 1 ° C. for 16 to 20 hours were uniformly dispersed in physiological saline to prepare a bacterial solution such that the number of bacteria per ml was about 10 8 . In addition, for Vibrio parahaemolyticus, an NA medium containing 3% NaCl (NA medium containing 3% sodium chloride) at 37 ± 1 ° C.
The test strain, which had been pre-cultured for 24 hours, was again inoculated into a 3% NaCl-added NA medium, and the cells cultured at 37 ± 1 ° C. for 16 to 20 hours were uniformly dispersed in a 3% sodium chloride solution.
A bacterial solution was prepared so that the number of bacteria per cell was about 10 8 .
A test solution was prepared by adding 4 ml of a 20% (W / V) ethanol solution of sample 2) to 80 ml of a 2.5% (V / V) solution of sample 1).

【0021】そして、試験液10mlに菌液1mlを接
種し、室温で作用させ、30分、1、3及び6時間後に
一白金耳量をNB培地(肉エキス0.2%を添加した普通
ブイヨン(栄研化学株式会社製))に接種・培養(37
℃、2日間培養)し、生育の有無を確認した。なお、腸
炎ビブリオについては、NB培地に代えて3%NaCl添
加NB培地(塩化ナトリウム3%を添加したNB培地)を用
いた。その結果を表4に示す。
Then, 10 ml of the test solution was inoculated with 1 ml of the bacterial solution, allowed to act at room temperature, and after 30 minutes, 1, 3, and 6 hours, one loopful was added to an NB medium (normal broth containing 0.2% meat extract). (Manufactured by Eiken Chemical Co., Ltd.)
C. for 2 days) to check for growth. For Vibrio parahaemolyticus, an NB medium supplemented with 3% NaCl (NB medium supplemented with 3% sodium chloride) was used instead of the NB medium. Table 4 shows the results.

【0022】[0022]

【表4】 表4 殺菌効果試験結果((財)日本食品分析センター調べ) 試 験 菌 生 育 の 有 無 30分後 1時間後 3時間後 6時間後 大腸菌(O157:H7 ) − − − − 大腸菌 − − − − 黄色ブドウ球菌 − − − − サルモネラ − − − − 腸炎ビブリオ − − − − [Table 4] Table 4 Bactericidal effect test results (according to Japan Food Research Laboratories) Test Bacterial growth Yes / No 30 minutes 1 hour 3 hours 6 hours later E. coli (O157: H7)----E. coli----Staphylococcus aureus----Salmonella ----Vibrio parahaemolyticus----

【0023】上記の実験結果から分かるように、大腸菌
(O157 :H7 )に対してスメルナーク単独では、原液
においては殺菌効果が認められるが、希釈すると効果が
認められない。カテキンについては殺菌効果は認められ
ない。ヒノキチオールについては殺菌効果が認められ
る。そして、スメクナールとヒノキチオールとを混合し
たものでは、大腸菌(O157 :H7 )に対してさらに強
い殺菌効果が認められ、また他の細菌類(大腸菌、黄色
ブドウ球菌、サルモネラ、腸炎ビブリオ)に対しても強
い殺菌効果が認められる。
As can be seen from the above experimental results, the use of Smernak alone against Escherichia coli (O157: H7) has a bactericidal effect in the stock solution, but no effect upon dilution. Catechin has no bactericidal effect. Hinokitiol has a bactericidal effect. The mixture of smectar and hinokitiol has a stronger bactericidal effect against Escherichia coli (O157: H7) and also against other bacteria (Escherichia coli, Staphylococcus aureus, Salmonella, Vibrio parahaemolyticus). A strong bactericidal effect is observed.

【0024】〔ゲル状物の製造〕ゲル状物1 スメルナーク2.5重量%、ヒノキチオール1.0重量
%、未変成アルコール(エタノール)5重量%、乳化剤
としてポリオキシエチレン硬化ヒマシ油(日本サーファ
クタント工業株式会社製 商品名 NIKKOL HC
O−50)2.0重量%及びポリオキシエチレン硬化ヒ
マシ油(日本サーファクタント工業株式会社製 商品名
NIKKOL HCO−60)2.0重量%、クエン
酸0.3重量%、クエン酸ソーダ0.2重量%、吸水性
樹脂(クラレ製 商品名 KIゲル 201K)4.0
重量%、残部イオン交換水となるような配合割合とし、
未変成アルコールにヒノキチオールを溶かし、アルコー
ルに溶かしたヒノキチオール、スメルナーク及びその他
の成分をイオン交換水に溶かし均一に混合した。次い
で、この混合液に吸水性樹脂を添加混合して淡黄色で半
透明のゲル状物1を得た。
[Production of gel-like material ] Gel-like material 1 Smernak 2.5% by weight, hinokitiol 1.0% by weight, undenatured alcohol (ethanol) 5% by weight, polyoxyethylene hydrogenated castor oil (Nippon Surfactant Industries, Ltd.) as an emulsifier Product name NIKKOL HC
O-50) 2.0% by weight and polyoxyethylene hydrogenated castor oil (trade name NIKKOL HCO-60, manufactured by Nippon Surfactant Industries, Ltd.) 2.0% by weight, citric acid 0.3% by weight, sodium citrate 0.2 % By weight, water-absorbing resin (trade name: KI gel 201K, manufactured by Kuraray) 4.0
Weight%, and the mixing ratio so that the balance becomes ion-exchanged water,
Hinokitiol was dissolved in undenatured alcohol, and hinokitiol, smernak and other components dissolved in the alcohol were dissolved in ion-exchanged water and mixed uniformly. Next, a water-absorbent resin was added to and mixed with this mixed solution to obtain a pale yellow translucent gel-like substance 1.

【0025】ゲル状物2 未変成アルコール(エタノール)の配合割合を20.0
重量%とした他は上記ゲル状物1において述べたと同様
に処理して淡黄色で半透明のゲル状物2を得た。上記ゲ
ル状物1及びゲル状物2はアルコールを含むためアルコ
ール臭を有するが、2〜3日間放置するとアルコールが
揮発してアルコール臭は消える。
Gel 2 The amount of the unmodified alcohol (ethanol) was adjusted to 20.0%.
The same treatment as described in Gel 1 above was carried out except that the amount was changed to% by weight, to obtain a pale yellow translucent gel 2. The gel 1 and the gel 2 contain alcohol and thus have an alcohol odor. However, when the gel is left for 2 to 3 days, the alcohol volatilizes and the alcohol odor disappears.

【0026】ゲル状物3 スメルナーク2.5重量%、ヒノキチオール1.0重量
%、クエン酸トリエチル3.0重量%、乳化剤としてポ
リオキシエチレン硬化ヒマシ油(日本サーファクタント
工業株式会社製 商品名 NIKKOL HCO−5
0)1.0重量%、吸水性樹脂(クラレ製 商品名 K
Iゲル 201K)4.0重量%、残部イオン交換水と
なるような配合割合とし、ヒノキチオール、クエン酸ト
リエチル、NIKKOL HCO−50を混合し、これ
にイオン交換水の一部を加えてミキサーで乳化した。次
いで、残りのイオン交換水及びスメルナークを加えて均
一に混合した。次いで、この混合液に吸水性樹脂を添加
混合して淡黄色で半透明のゲル状物3を得た。このゲル
状物3は略無臭であった。
Gel 3 : 2.5% by weight of Smernak, 1.0% by weight of hinokitiol, 3.0% by weight of triethyl citrate, polyoxyethylene hydrogenated castor oil as emulsifier (product name NIKKOL HCO-, manufactured by Nippon Surfactant Industries, Ltd.) 5
0) 1.0% by weight, water-absorbent resin (trade name K manufactured by Kuraray)
I-gel 201K) 4.0 wt%, the balance being ion-exchanged water, hinokitiol, triethyl citrate, and NIKKOL HCO-50, and a portion of ion-exchanged water was added thereto and emulsified with a mixer. did. Next, the remaining ion-exchanged water and Smernak were added and mixed uniformly. Next, a water-absorbent resin was added to and mixed with this mixture to obtain a pale yellow translucent gel-like substance 3. This gel 3 was substantially odorless.

【0027】〔ゲル状物の抗菌効果試験〕検体1)とし
てゲル状物3、検体2)としてゲル状物2を用い、図1
に示すように、ゲル状物(検体)10を容器11に詰
め、各種細菌の菌液をそれぞれ塗抹した平板培地12
を、検体10とともに密閉容器(約2.7リットル)1
3に入れて10℃、35℃で培養後、生菌数を測定し
た。
[Test of antibacterial effect of gel-like material] A gel-like material 3 was used as a sample 1) and a gel-like material 2 was used as a sample 2).
As shown in FIG. 1, a gel material (specimen) 10 was packed in a container 11 and a plate medium 12 coated with bacterial solutions of various bacteria.
Into a sealed container (about 2.7 liters)
After culturing at 10 ° C. and 35 ° C. in No. 3, the viable cell count was measured.

【0028】試験菌株として上記実験例4において用い
たものと同様のものを用い、大腸菌(O157 : H7 )、
大腸菌、黄色ブドウ球菌及びサルモネラについては、NA
培地(普通寒天培地(栄研化学株式会社製))で37±
1℃、16〜24時間前培養した試験菌株をNA培地に再
度接種して37±1℃、16〜20時間培養した菌体を
リン酸緩衝液に均一に分散させ、1ml当たりの菌数が
約103 となるように菌液を調製した。また、腸炎ビブ
リオについては、3%NaCl添加NA培地(塩化ナトリ
ウム3%を添加したNA培地)で37±1℃、16〜24
時間前培養した試験菌株を3%NaCl添加NA培地に再
度接種して37±1℃、16〜20時間培養した菌体を
3%塩化ナトリウム溶液に均一に分散させ、1ml当た
りの菌数が約103 となるように菌液を調製した。
The same test strain as that used in Experimental Example 4 above was used, and Escherichia coli (O157: H7),
For E. coli, Staphylococcus aureus and Salmonella, NA
37 ± in the medium (normal agar medium (Eiken Chemical Co., Ltd.))
The test strain pre-cultured at 1 ° C. for 16 to 24 hours was again inoculated into an NA medium, and the cells cultured at 37 ± 1 ° C. for 16 to 20 hours were uniformly dispersed in a phosphate buffer. A bacterial solution was prepared to be about 10 3 . As for Vibrio parahaemolyticus, a medium containing 3% NaCl (NA medium containing 3% sodium chloride) at 37 ± 1 ° C., 16 to 24 ° C.
The test strain pre-cultured for 3 hours is again inoculated into 3% NaCl-added NA medium, and the cells cultured at 37 ± 1 ° C. for 16 to 20 hours are uniformly dispersed in a 3% sodium chloride solution. A bacterial solution was prepared to be 10 3 .

【0029】そして、大腸菌(O157 : H7 )、大腸
菌、黄色ブドウ球菌及びサルモネラについては、SA平板
培地(標準寒天培地(栄研化学株式会社製))12に菌
液0.1mlを塗抹後、検体10とともに密閉容器13
に入れ、10℃ 7日間及び35℃ 2日間培養して、
生菌数を測定した。腸炎ビブリオについては、SA平板培
地に代えて3%NaCl添加SA平板培地(塩化ナトリウ
ム3%を添加したSA培地)を用いた。また、検体10を
入れずに培養したもの(対照)も同様に試験した。その
結果を表5に示す。表5において符号「―」は菌体が生
育しなかったことを示す。
For Escherichia coli (O157: H7), Escherichia coli, Staphylococcus aureus and Salmonella, 0.1 ml of the bacterial solution was spread on an SA plate medium (standard agar medium (manufactured by Eiken Chemical Co., Ltd.)) 12. Closed container 13 with 10
And incubated at 10 ° C for 7 days and at 35 ° C for 2 days.
The number of viable bacteria was measured. For Vibrio parahaemolyticus, an SA plate medium supplemented with 3% NaCl (SA medium supplemented with 3% sodium chloride) was used instead of the SA plate medium. In addition, those cultured without the specimen 10 (control) were also tested in the same manner. Table 5 shows the results. In Table 5, the symbol "-" indicates that the cells did not grow.

【0030】[0030]

【表5】表5 抗菌力試験結果((財)日本食品分析センター調べ) 試 験 菌 試 料 平板1枚当たりの生菌群数 35℃培養 10℃培養 大 腸 菌 検体1) 0 0 (O157:H7 ) 検体2) 0 0 対 照 91 179 検体1) 0 0 大 腸 菌 検体2) 0 0 対 照 49 141 検体1) 0 ― 黄色ブドウ球菌 検体2) 0 ― 対 照 96 検体1) 0 0 サルモネラ 検体2) 0 0 対 照 95 76 検体1) 0 ― 腸炎ビブリオ 検体2) 0 ― 対 照 37 ― [Table 5] Table 5 Antibacterial activity test results (according to Japan Food Research Laboratories) Test bacteria Number of viable bacteria per plate 35 ° C culture 10 ° C culture colon bacterium Sample 1) 0 (O157: H7) Sample 2) 0 0 Control 91 179 samples 1) 0 0 E. coli sample 2) 0 0 Control 49 141 Sample 1) 0-Staphylococcus aureus Sample 2) 0- Control 96 - Sample 1) 0 0 Salmonella Sample 2) 0 0 Vs. irradiation 95 76 sample 1) 0 - Vibrio parahaemolyticus sample 2) 0 - versus irradiation 37 -

【0031】表5の結果から、本発明の抗菌剤をゲル状
物とした場合にも、ゲル状物から揮発した有効成分が各
種細菌に対して高い抗菌効果を示すことが分かる。な
お、黄色ブドウ球菌及び腸炎ビブリオについては、10
℃では菌体が生育せず、低温に弱いことが分かる。
From the results shown in Table 5, it can be seen that even when the antibacterial agent of the present invention is made into a gel, the active ingredient volatilized from the gel shows a high antibacterial effect on various bacteria. In addition, about Staphylococcus aureus and Vibrio parahaemolyticus, 10
At ℃, the cells did not grow, indicating that the cells were weak to low temperatures.

【0032】〔ゲル状物の消臭効果試験〕上記したゲル
状物1(G1)180g及びゲル状物2(G2)170
gを直径72mm、高さ55mmの容器に所定量詰め、
容器の上部を開放した状態で、種々の場所に設置して消
臭効果を試験した。その結果を表6に示す。
[Test for deodorizing effect of gel-like material] 180 g of gel-like material 1 (G1) and 170 of gel-like material 2 (G2) 170
g in a container having a diameter of 72 mm and a height of 55 mm,
With the upper part of the container opened, it was installed in various places to test the deodorizing effect. Table 6 shows the results.

【0033】[0033]

【表6】 表 6 試験品 G1 G1 G1 G1 G1 G2 G2 設置場所 トイレ 冷蔵庫 台所・室内 事務所 車内 トイレ 冷蔵庫 平均広さ 220 l 8畳 14.4畳 283 l 手配個数 平均設置 日数(日) 32.5 35.3 32.5 26.6 25.5 26 23.7 平均減少 量/日(g) 1.8 2.19 2.72 3.82 4.16 0.92 2.31 平均温度 (℃) 10 5 16.5 22.8 25 10 5 平均湿度 (%) 50 53 臭チェック 良好 良好 良好 良好 良好 良好 良好 鮮度保持 チェック 良好 良好 Table 6 specimens G1 G1 G1 G1 G1 G2 G2 location toilet Refrigerator Kitchen-room office interior toilet refrigerator average size 220 l 8 tatami mats 14.4 tatami mats 283 l Number of arrangements 2 6 2 5 2 1 3 Average installation days (days) 32.5 35.3 32.5 26.6 25.5 26 23.7 Average reduction / day (g) 1.8 2.19 2.72 3.82 4.16 0.92 2.31 Average temperature (℃) 10 5 16.5 22.8 25 10 5 Average humidity (%) 50 53 Odor check good good good good good good good freshness retention check good good

【0034】表6の結果から、いずれの設置場所におい
ても消臭効果が良好であることが分かる。また、冷蔵庫
内に設置した場合には、庫内に置いた野菜などの生鮮食
料品の鮮度はゲル状物を設置しない場合に比べ20〜4
0%程度長く保持された。これは、抗菌効果が発揮され
たためと考えられる。
From the results shown in Table 6, it can be seen that the deodorizing effect is good at any installation location. In addition, when installed in a refrigerator, freshness of fresh food such as vegetables placed in the refrigerator is 20 to 4 times higher than when no gel-like material is installed.
It was held for about 0% longer. This is probably because the antibacterial effect was exhibited.

【0035】〔重金属類、毒物等の含有分析試験〕ゲル
化剤を添加しなかった他はゲル状物3において述べたと
同様に処理して得た液状物について、重金属類、毒物等
の含有分析試験を行った。その結果を表7に示す。表7
の結果から、本発明の抗菌剤から重金属類や毒物等は検
出されていないことが分かる。
[Analysis of Content of Heavy Metals, Poisons, etc.] The analysis of the content of heavy metals, poisons, etc. was carried out on the liquid obtained by the same treatment as described for the gel 3 except that the gelling agent was not added. The test was performed. Table 7 shows the results. Table 7
It can be seen from the results that no heavy metals or toxic substances were detected from the antibacterial agent of the present invention.

【0036】[0036]

【表7】 表7 分析試験結果((財)日本食品分析センター調べ) 分析試験項目 結 果 検出限度 分 析 方 法 EPN 検出せず 0.05ppm ガスクロマトグラフ法 パラチオン 検出せず 0.05ppm ガスクロマトグラフ法 メチルジメトン 検出せず 0.05ppm ガスクロマトグラフ法 メチルパラチオン 検出せず 0.05ppm ガスクロマトグラフ法 ヒ素(Asとして) 検出せず 0.1ppm DDTC-Ag 吸光光度法 鉛 検出せず 0.05ppm 原子吸光光度法 カドミウム 検出せず 0.01ppm 原子吸光光度法 総水銀 検出せず 0.01ppm 還元気化原子吸光光度法 総クロム 検出せず 0.5ppm ジフェニルカルバジド吸光光度法シアン 検出せず 0.1ppm ピリジンピラゾロン吸光光度法 [Table 7] Table 7 Analytical test results (according to Japan Food Research Laboratories ) Analytical test items Results Detection limit analysis method EPN not detected 0.05 ppm gas chromatographic method Parathion not detected 0.05 ppm gas chromatographic method Methyl dimeton detection Not detected 0.05 ppm Gas chromatographic method Methyl parathion Not detected 0.05 ppm Gas chromatographic method Arsenic (as As) Not detected 0.1 ppm DDTC-Ag Spectrophotometric method Lead Not detected 0.05 ppm Atomic spectrophotometric method Cadmium Not detected 0.01 ppm Atomic absorption method Photometric method Total mercury not detected 0.01 ppm reduced vapor atomic absorption spectrophotometric method Total chromium not detected 0.5 ppm diphenylcarbazide spectrophotometric method Cyan Not detected 0.1 ppm pyridinepyrazolone spectrophotometric method

【0037】〔マウスにおける急性経口毒性試験〕上記
重金属類、毒物等の含有分析試験において用いたものと
同じ液状物を検体として、OECD化学物質毒性試験指
針(1987)に準拠し、マウスにおける急性経口毒性試験
(限度試験)を財団法人日本食品分析センターにて行っ
た。
[Acute Oral Toxicity Test in Mice] The same liquid substance used in the above-mentioned analysis test for heavy metals, toxic substances, etc. was used as a sample, and an acute oral toxicity test in mice was carried out in accordance with the OECD Guideline for Chemical Toxicity Test (1987). A toxicity test (limit test) was performed at the Japan Food Research Laboratories.

【0038】試験動物として、4週齢のICR系雌雄マ
ウスを日本エスエルシー株式会社から購入し、約1週間
の予備飼育を行って健康に異常のないことを確認した
後、試験に使用した。試験動物はポリカーボネート製ケ
ージに各5匹収容し、室温23±2℃、照明時間12時
間/日に設定した飼育室において飼育した。飼料(マウ
ス・ラット用固形飼料(ラボMRストック、日本農産工業
株式会社製))及び飲料水(水道水)は自由に摂取させ
た。
As test animals, 4-week-old ICR male and female mice were purchased from Japan SLC Co., Ltd., and were preliminarily reared for about one week to confirm that there was no abnormality in their health. Five test animals were housed in polycarbonate cages, each being housed in a breeding room set at a room temperature of 23 ± 2 ° C. and an illumination time of 12 hours / day. Feed (mouse / rat solid feed (Lab MR Stock, manufactured by Nihon Nosan Kogyo Co., Ltd.)) and drinking water (tap water) were allowed to be taken freely.

【0039】そして、試験群及び対照群ともに雌雄それ
ぞれ10匹を用い、投与前約4時間試験動物を絶食させ
た。体重を測定した後、試験群では雌雄ともに20ml/
kgの用量で検体を胃ゾンデを用いて強制単回経口投与し
た。対照群には雄では0.6ml、雌では0.5mlの精製
水を同様に投与した。観察期間は14日間とし、投与日
は頻回、翌日から1日1回の観察を行った。投与後1週
ごとに体重を測定し、t−検体により有意水準5%で群
間の比較を行った。試験期間終了時に動物すべてを剖検
した。
The test and control groups each used 10 males and 10 females, and the test animals were fasted for about 4 hours before administration. After measuring the body weight, in the test group, 20 ml /
Specimens were given a single oral gavage at a dose of kg using a gastric probe. The control group received 0.6 ml of purified water for males and 0.5 ml for females in the same manner. The observation period was 14 days, and the administration was performed frequently on the administration day and once a day from the next day. Body weight was measured every week after administration, and comparison between groups was performed at a significance level of 5% using t-samples. All animals were necropsied at the end of the study period.

【0040】上記試験の結果、雌雄ともに観察期間中に
死亡例は認められなかった。臨床症状として、試験群で
は、雌雄ともに投与後数分から全例で自発運動の低下が
見られ、雄で2例、雌で1例に苦悶反応及び体姿勢の異
常(腹臥位)が見られた。また、雌雄それぞれ4例によ
ろめき歩行も見られた。苦悶反応は投与後30分後に、
その他の症状も5時間後にはおおむね回復し、投与後1
日以降には異常は見られなかった。対照群では、観察期
間を通して異常は見られなかった。体重変化として、投
与後1週及び2週の体重を測定した結果を表8に示す。
体重は平均値±標準偏差で表した(単位:g)。括弧内
に動物数を示した。この体重測定では、雌雄ともに試験
群と対照群の間で体重増加に差は見られなかった。剖検
所見として、観察期間終了後の剖検では、雌雄ともに各
群で主要臓器に異常は認められなかった。
As a result of the above test, no deaths were observed during the observation period for both males and females. As a clinical symptom, in the test group, a decrease in locomotor activity was observed in all cases from a few minutes after administration in both males and females, writhing reaction and abnormal body posture (prone position) were observed in 2 males and 1 female. Was. In addition, staggered walking was also observed in four males and four females. The agony reaction was 30 minutes after administration,
Other symptoms generally recovered after 5 hours, and 1 hour after administration.
No abnormalities were seen after the day. In the control group, no abnormality was observed throughout the observation period. Table 8 shows the results of measuring the body weight at 1 week and 2 weeks after administration as a change in body weight.
The body weight was represented by a mean value ± standard deviation (unit: g). The number of animals is shown in parentheses. This weight measurement showed no difference in weight gain between the test group and the control group in both sexes. Necropsy findings showed no major organ abnormalities in each group in both sexes at necropsy after the observation period.

【0041】OECD化学物質毒性試験指針(1987)で
は、検体が液体の場合、投与量は体重100g当たり2
ml(20ml/kg)を越えるべきではないと指示してお
り、本試験ではこの投与し得る最高用量で死亡例は認め
られず、剖検時にも異常は見られなかった。従って、検
体のマウスにおける単回経口投与による致死量は、雌雄
ともに20ml/kg以上であるものと認められた。
According to the OECD Guidelines for Chemical Toxicity Test (1987), when the sample is a liquid, the dose is 2 per 100 g of body weight.
ml (20 ml / kg) should not be exceeded, and no deaths were observed at the highest dose that could be administered in this study, and no abnormalities were seen at necropsy. Therefore, it was confirmed that the lethal dose of a single oral administration of the sample to mice was 20 ml / kg or more for both males and females.

【0042】[0042]

【表8】 表8 体重変化 投与群 投与前 投与後 7日 14日 試験群 27.1±0.9(10) 31.3±1.5(10) 34.8±2.0(10) 雄 対照群 27.4±1.0(10) 32.6±1.6(10) 36.0±2.0(10) 試験群 22.9±0.6(10) 24.7±1.1(10) 28.2±1.7(10) 雌 対照群 22.5±0.5(10) 25.6±1.1(10) 28.2±1.8(10) Table 8 Weight change administration group Before administration After administration 7 days 14 days test group 27.1 ± 0.9 (10) 31.3 ± 1.5 (10) 34.8 ± 2.0 (10) male control group 27.4 ± 1.0 (10) 32.6 ± 1.6 (10) 36.0 ± 2.0 (10) test group 22.9 ± 0.6 (10) 24.7 ± 1.1 (10) 28.2 ± 1.7 (10) Female control group 22.5 ± 0.5 (10) 25.6 ± 1.1 (10) 28.2 ± 1.8 (10)

【0043】[0043]

【発明の効果】以上説明したように本発明の消臭性を付
与した抗菌剤によれば、植物由来の成分をその有効成分
としており安全性が高く、消臭性と抗菌効果とを併せも
たせることができる。また、本発明の消臭性を付与した
抗菌剤をゲル状物とすることにより、有効成分の揮発を
促し、消臭及び抗菌効果を高めることができる。特に病
原性大腸菌O157などの食中毒菌に対して高い抗菌効
果が得られる。
As described above, according to the antibacterial agent imparted with deodorizing properties of the present invention, a plant-derived component is used as its active ingredient, so that it is highly safe and has both deodorizing properties and antibacterial effects. be able to. Further, by making the antibacterial agent imparted with deodorant properties of the present invention a gel, it is possible to promote the volatilization of the active ingredient and enhance the deodorant and antibacterial effects. In particular, a high antibacterial effect is obtained against food poisoning bacteria such as pathogenic Escherichia coli O157.

【図面の簡単な説明】[Brief description of the drawings]

【図1】ゲル状物の抗菌効果試験方法の説明図。FIG. 1 is an explanatory diagram of a method for testing an antibacterial effect of a gel.

【符号の説明】[Explanation of symbols]

10 ゲル状物(検体) 11 容器 12 平板培地 13 密閉容器 Reference Signs List 10 Gel-like substance (sample) 11 Container 12 Plate medium 13 Sealed container

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】商品名スメルナークとトロポロン骨格をも
つ有機物とを含んでなることを特徴とする消臭性を付与
した抗菌剤。
1. An antibacterial agent having deodorant properties, comprising Smernak (trade name) and an organic substance having a tropolone skeleton.
【請求項2】前記商品名スメルナークとトロポロン骨格
をもつ有機物に加えて、さらに乳化剤を含有してなる請
求項1に記載の消臭性を付与した抗菌剤。
2. The deodorant-providing antibacterial agent according to claim 1, further comprising an emulsifier in addition to the organic substance having a trade name of Smernaq and a tropolone skeleton.
【請求項3】前記トロポロン骨格をもつ有機物はヒノキ
チオールである、請求項1又は2に記載の消臭性を付与
した抗菌剤。
3. The antibacterial agent imparted with deodorant properties according to claim 1, wherein the organic substance having a tropolone skeleton is hinokitiol.
【請求項4】さらにゲル化剤を添加してゲル状物とした
請求項1〜3のいずれか1項に記載の消臭性を付与した
抗菌剤。
4. The antibacterial agent having a deodorant property according to claim 1, wherein a gelling agent is further added to form a gel.
JP9135928A 1997-05-08 1997-05-08 Antimicrobial agent to which deodorizability is imparted Pending JPH10305088A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9135928A JPH10305088A (en) 1997-05-08 1997-05-08 Antimicrobial agent to which deodorizability is imparted

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9135928A JPH10305088A (en) 1997-05-08 1997-05-08 Antimicrobial agent to which deodorizability is imparted

Publications (1)

Publication Number Publication Date
JPH10305088A true JPH10305088A (en) 1998-11-17

Family

ID=15163134

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9135928A Pending JPH10305088A (en) 1997-05-08 1997-05-08 Antimicrobial agent to which deodorizability is imparted

Country Status (1)

Country Link
JP (1) JPH10305088A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005272328A (en) * 2004-03-24 2005-10-06 Zenji Fukami Deodorant and antimicrobial composition
WO2018079620A1 (en) * 2016-10-28 2018-05-03 株式会社カネカ Gelatinous composition

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005272328A (en) * 2004-03-24 2005-10-06 Zenji Fukami Deodorant and antimicrobial composition
WO2018079620A1 (en) * 2016-10-28 2018-05-03 株式会社カネカ Gelatinous composition
JPWO2018079620A1 (en) * 2016-10-28 2019-09-19 株式会社カネカ Gel composition

Similar Documents

Publication Publication Date Title
Al-Ahmad et al. Biodegradability of cefotiam, ciprofloxacin, meropenem, penicillin G, and sulfamethoxazole and inhibition of waste water bacteria
US4978686A (en) Method of protecting crops by a non-toxic composition
Spooner et al. Chapter IV Laboratory assessment of antibacterial activity
NO311494B1 (en) Dosage form for treatment of microbiological conditions in humans or animals, method of sterilization of disposable articles, sterilizing mixture, as well as animal feed supplements
Obame et al. Antioxidant and antimicrobial activities of Canarium schweinfurthii Engl. Essential oil from Centrafrican Republic
Adera et al. Physicochemical properties and biological activities of garden cress (Lepidium sativum L.) seed and leaf oil extracts
Scott et al. Escherichia coli O157: H7 converts plant-derived choline to glycine betaine for osmoprotection during pre-and post-harvest colonization of injured lettuce leaves
US20070160725A1 (en) Use of extracts and compounds of allium-genus plants as preservatives in the food and agri-food industries
JPH10305088A (en) Antimicrobial agent to which deodorizability is imparted
KR101706284B1 (en) Fumigation type compositions having antimicrobial and antifungal activity and Fumigation apparatus comprising the same
CN1915041A (en) Product of antistaling agent for vegetable, fruit, and its applications
JPH11228433A (en) Antibacterial agent imparted with deodorizing ability
Gherairia et al. Antibacterial activity of essential oils from two species of genus thymus growing in different sites of north eastern Algerian
Steponavičienė et al. Modelling the ozone penetration in a grain layer
CN104256849A (en) A mold-killing composition and applications thereof
Shehu et al. Antibacterial activity and antioxidant capacity of Malaysian tualang honey
KR100439124B1 (en) Manufacturing process of Rock Composition for Magma Q water having antivirus and sterilization
Alzahrani et al. An evaluation of some chemical and natural agents for their antifungal activities against Aspergillus niger as a contamination fungal in indoor environment
WO1998012924A1 (en) Method for preparing sterilizing solutions, sterilizing solutions, and sterilizing media
KR20060006709A (en) Nano silver or perfume raw materials contain papering walls adhesives
Harness III Sanitization Effectiveness of Alkaline-Dissolved Essential Oils as Organic Produce Washing Solutions
US10426163B1 (en) Bactericidal method of using compounds of fatty acids and ammonium fatty acid salts
Alfassam et al. Household Essential Oils as Antimicrobial Agents for Health and Skin care
Bobkova et al. Selected parameters of quality and safety of herbal tea.
White Pelargonic Acid Emulsion as a Postharvest Sanitizer to Reduce Salmonella Contamination on Tomatoes